angiotensin ii, des-phe(8)- has been researched along with Bone Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alabsi, W; Hay, M; Largent-Milnes, TM; Polt, R; Sulaiman, MI; Szabo, L; Vanderah, TW | 1 |
| Arnold, MR; Forte, BL; Hay, M; Largent-Milnes, TM; Slosky, LM; Staatz, WD; Vanderah, TW; Zhang, H | 1 |
| Dubey, P; Gallagher, PE; Krishnan, B; Smith, TL; Tallant, EA; Torti, FM; Willingham, MC; Zapadka, ME | 1 |
3 other study(ies) available for angiotensin ii, des-phe(8)- and Bone Neoplasms
| Article | Year |
|---|---|
PNA6, a Lactosyl Analogue of Angiotensin-(1-7), Reverses Pain Induced in Murine Models of Inflammation, Chemotherapy-Induced Peripheral Neuropathy, and Metastatic Bone Disease.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cancer Pain; Disease Models, Animal; Female; Humans; Hyperalgesia; Mice; Mice, Inbred C57BL; Neuralgia; Oxaliplatin | 2023 |
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
Topics: Analgesics; Analysis of Variance; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Imidazoles; Losartan; Mice; Mice, Inbred BALB C; Nesting Behavior; Peptide Fragments; Pyridines; Rotarod Performance Test | 2016 |
Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis.
Topics: Adenocarcinoma; Aged; Angiotensin I; Animals; Antineoplastic Agents; Bone Marrow Cells; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Nude; Mice, SCID; Middle Aged; Neoplasm Metastasis; Osteoclasts; Peptide Fragments; Prostatic Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |